Drug intelligence / Profile preview

Nutri-n

Development stage: Unknown
Lead developer: Nilegenix
Administration: Oral

Overview

Nutri-n is a nutritional supplement developed and marketed by Nilegenix, a generic pharmaceutical company based in Sangli, Maharashtra, India. Available in both tablet and capsule formulations, the product is designed to support metabolic energy levels, enhance immune system function, and promote general physiological health. As a commercialized generic formulation, it is intended for daily nutritional support and is currently marketed as an approved product in India.

Brand names: Nutri-n
Other names: Nutri-n TabletNutri-n Capsule

Beyond the preview

Go deeper on Nutri-n.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nutri-n.

Explore the full profile